Drawing based on the label description. No photo yet.
40 217 pill
Pill with imprint 40 217 is white, capsule, 6 mm and has been identified as Lisdexamfetamine Dimesylate 40 mg. It is supplied by Granules Pharmaceuticals Inc.
Controlled substance: Schedule II
Lisdexamfetamine Dimesylate 40 mg
- Imprint
- 40 217
- Strength
- 40 mg
- Color
- White
- Shape
- Capsule / oblong
- Size
- 6 mm
- Score
- No score line
- Form
- Tablet, chewable
- Manufacturer
- Granules Pharmaceuticals Inc
- NDC
- 70010-217, 70010-217-01
Is this your pill? Check every detail
- The imprint reads exactly 40 217, on the same sides.
- It is white, capsule, 6 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Lisdexamfetamine Dimesylate
Inactive: Silicon Dioxide, Croscarmellose Sodium, Guar Gum, Magnesium Stearate, Mannitol, Microcrystalline Cellulose, Sucralose
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
11 A
Mirtazapine 7.5 mg
White, capsule, 7 mm
- J64 Dapsone 25 mg White, capsule, 7 mm
- 11 4 Buprenorphine Hydrochloride and Naloxone Hydrochloride 11.4 mg / 2.9 mg White, capsule, 7 mm Schedule III
- R5 Risperidone 0.5 mg White, capsule, 7 mm
- D 98 Lamotrigine 5 mg White, capsule, 7 mm
- 317 G Norethindrone and Ethinyl Estradiol White, capsule, 7 mm
Other Lisdexamfetamine Dimesylate pills
- 10 214 Lisdexamfetamine Dimesylate 10 mg White, round, 7 mm Schedule II
- 10 S489 Lisdexamfetamine Dimesylate 10 mg White, round, 7 mm Schedule II
- 10 S83 Lisdexamfetamine Dimesylate 10 mg White, round, 7 mm Schedule II
- 20 215 Lisdexamfetamine Dimesylate 20 mg White, hexagon, 10 mm Schedule II
- 20 S489 Lisdexamfetamine Dimesylate 20 mg White, hexagon, 10 mm Schedule II
- 20 S84 Lisdexamfetamine Dimesylate 20 mg White, hexagon, 10 mm Schedule II
- 30 216 Lisdexamfetamine Dimesylate 30 mg White, triangle, 11 mm Schedule II
- 30 S489 Lisdexamfetamine Dimesylate 30 mg White, triangle, 11 mm Schedule II